Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries Limited American Depositary Shares
(NY:
TEVA
)
16.94
+0.07 (+0.41%)
Official Closing Price
Updated: 7:00 PM EDT, May 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries Limited American Depositary Shares
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
Joblessness Surprise
July 22, 2021
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.
Via
Talk Markets
Panic Attack
July 21, 2021
The H1 rise in US markets was based on hope for an end to lockdowns.
Via
Talk Markets
Understanding Teva Pharmaceutical Indus's Unusual Options Activity
July 21, 2021
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $8.98. Sentiment...
Via
Benzinga
Teva Announces Changes to Executive Management Team
July 21, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
“Claw-Back” day
July 20, 2021
The rally was just as irrational as the selloff.
Via
Talk Markets
Drug Stocks McKesson, AmerisourceBergen Pop On Reports Of $26 Billion Settlement In Opioid Fight
July 20, 2021
Drug stocks popped Tuesday on reports they could pay $21 billion to settle claims they helped fuel the nation's opioid epidemic.
Via
Investor's Business Daily
Topics
Lawsuit
Exposures
Financial
Legal
Delta Defeats Bulls
July 19, 2021
Stocks tended to crash without rhyme or reason.
Via
Talk Markets
Unusual Options Activity Insight: Teva Pharmaceutical Indus
July 19, 2021
On Monday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved down to $8.38. Sentiment: BULLISH Option...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 19, 2021
Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows. Noteworthy Points: The largest company by market cap to set a new 52-week...
Via
Benzinga
Weak Week
July 16, 2021
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism.
Via
Talk Markets
Selloff Round 3
July 13, 2021
Stocks fell across the board in foreign countries, except for Britain which was upbeat.
Via
Talk Markets
Yellow Card
July 12, 2021
The price of oil fell about 1% today.
Via
Talk Markets
Analyzing Teva Pharmaceutical Indus's Unusual Options Activity
July 12, 2021
On Monday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved up to $9.31. Sentiment: BEARISH Option...
Via
Benzinga
Recovery Friday
July 09, 2021
The big winners this week were Financials.
Via
Talk Markets
Biohaven Stock Hits Record High As Migraine Drug Trounces Quarterly Forecasts
July 07, 2021
Biohaven crushed Wall Street's expectations for second-quarter sales of migraine drug Nurtec on Tuesday, leading BHVN stock to pop.
Via
Investor's Business Daily
Sell Sell Sell
July 06, 2021
Today the inevitable reversal of wild gains overtook Wall Street, echoing what occurred in major foreign markets Monday.
Via
Talk Markets
People Needed
July 02, 2021
If qualified people are not looking for work, they will have to be lured to do so with higher wages.
Via
Talk Markets
Exposures
Labor
Teva Recalls One Batch Of Topotecan After Complaint Of Glass Particulate In Vial
July 02, 2021
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is recalling one lot of its cancer drug topotecan injection after a pharmacy complaint flagged the presence of a single glass...
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021
July 01, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
End Of June
June 30, 2021
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Lots Of Deal News
June 29, 2021
Today Didi, a Chinese ride-hailing stock is doing its IPO reportedly at above the level projected in its application.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid
June 29, 2021
Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly...
Via
Benzinga
JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst
June 28, 2021
Over the weekend, Johnson & Johnson (NYSE:JNJ) reached a ...
Via
Benzinga
Teva and Bioeq Announce Commercial Partnership for Biosimilar
June 28, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Johnson & Johnson Reaches $230M Settlement With New York To End Sale Of Opioids Nationwide
June 26, 2021
The company has said that it has not marketed opioids in the U.S. since 2015 and discontinued the business in 2020. JNJ did not admit liability in settling with New York State, Nassau, and Suffolk...
Via
Talk Markets
Johnson & Johnson Reaches $230M Settlement With New York State To End Sale Of Opioids Nationwide
June 26, 2021
On Saturday, Johnson & Johnson (NYSE: JNJ) said it would end the manufacture and sale of opioids nationwide in a $230 million settlement with the New York state,...
Via
Benzinga
Summer Friday
June 25, 2021
The stock market tried for another record after yesterday's late blowout over the infrastructure deal.
Via
Talk Markets
Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults
June 23, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Reconsidered Boom
June 22, 2021
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded.
Via
Talk Markets
Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States
June 22, 2021
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.